Mindfulness Based Stress Reduction in COPD
1 other identifier
interventional
20
1 country
1
Brief Summary
The objective of this study is to test the efficacy of a Mindfulness Based Stress Reduction program in COPD on quality of life, dyspnea, daily physical activity and mindfulness during daily life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1 chronic-obstructive-pulmonary-disease
Started Feb 2010
Typical duration for phase_1 chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2010
CompletedFirst Posted
Study publicly available on registry
January 28, 2010
CompletedStudy Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedMarch 21, 2016
March 1, 2016
7 months
January 27, 2010
March 17, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
We hypothesize that the perception of well being will increase after participants go through the MBSR program for COPD.
Baseline and at eight weeks
Secondary Outcomes (1)
Participants in the MBSR for COPD will have an increase in their physical activity level.
Baseline and 8 weeks
Study Arms (1)
MBSR
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- clinical diagnosis of COPD
- clinically significant dyspnea, as determined by a score of \>=2 on the Medical Research Council of Dyspnea Score questionnaire (0-4).
You may not qualify if:
- patients with a high likelihood of not completing the program (active chemical dependency)
- patients with an inability fo provide good data or to follow commands (neurologic or psychiatric condition).
- poor motivation or lack of interest in program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roberto Benzo, MD
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
January 27, 2010
First Posted
January 28, 2010
Study Start
February 1, 2010
Primary Completion
September 1, 2010
Study Completion
December 1, 2010
Last Updated
March 21, 2016
Record last verified: 2016-03